4-(2-Hy-droxy-phen-yl)-3,5-di-thia-hepta-ne-dioic acid.

In the crystal of the title compound, C11H12O5S2, mol-ecules are linked by O-H⋯O hydrogen bonds and C-H⋯O inter-actions, forming a three-dimensional network.

(E)-3-(4-Meth-oxy-phen-yl)-3-[3-(4-meth-oxy-phen-yl)-1H-pyrazol-1-yl]prop-2-enal.

In the title mol-ecule, C20H18N2O3, the pyrazole ring forms a dihedral angle of 2.2 (1)° with its meth-oxy-phenyl substituent and a dihedral angle of 67.2 (1)° with the benzene substituent on the propenal unit.

1-(2,4-Dinitro-phen-yl)-3-phenyl-4-phenyl-sulfanyl-1H-pyrazole.

In the title mol-ecule, C(21)H(14)N(4)O(4)S, the pyrazole ring forms dihedral angles of 45.6 (1), 87.7 (1) and 27.

Selective one-pot multicomponent synthesis and anti-tubercular evaluation of 5-(aryl/cyclohexylsulfanyl)-2-alkoxy-4,6-diarylnicotinonitriles.

A new set of highly substituted pyridine derivatives has been synthesized by a product selective four component reaction of aryl aldehyde, malononitrile and 2-aryl/cyclohexylsulfanyl-1-aryl-1-ethanones in presence of sodium hydroxide in methyl/ethyl alcohol. Among the compounds, 4,6-bis(4-chlorophenyl)-5-[(4-chlorophenyl)sulfanyl]-2-methoxynicotinonitrile (4n) inhibited Mycobacterium tuberculosis (MTB) with minimum inhibitory concentration (MIC) of 3.1 microM and was more potent than ethambutol and pyrazinamide.